Home Tags SH UCL
SH UCL Related Content
Jane Kinghorn, Director at UCL Translational Research Office and Nick McNally, Managing Director Research UCL/UCLH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.
Case study: UCL researchers and dental materials manufacturer collaborate to speed up the development of a new dental filling material for children.
Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office), at University College London (UCL), explain the value of drug discovery in academia in bridging the “Valley of Death”.
Jane Kinghorn, along with Marta Ribeiro, Felipe Fouto, and Colby Benari from UCL, argues that the ability to listen and learn makes UCL a global partner of choice for health research & innovation.
Jane Kinghorn, Director of the Translational Research Office at UCL, discusses the importance of research and partnership in improving the health and wealth of the UK.
UCL’s Translational Research Office (TRO) builds on an increasingly vibrant translational culture across the university community.
A new direction in the monitoring of brain injury in babies, pioneered by a team of physicists, engineers and doctors in University College London (UCL) and University College London Hospitals (UCLH)